Searched for
PHARMA CMO
Aurobindo Pharma arm extends negotiations deadline with MSD for contract manufacturing operationsAurobindo Pharma extends deadline for CuraTeQ Biologics and Merck Sharp & Dohme Singapore negotiations on contract manufacturing operations...28 Mar, 2024, 10.31 PM IST- AstraZeneca Pharma India plans to sell Bengaluru plantThe company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as ...16 Nov, 2023, 06.10 PM IST
- Jefferies initiates coverage on JB Pharma with a 'buy' tag; stock hits 52-week highJefferies has given a target of Rs 2,680 to JB Pharmaceuticals,respectively based on 20x June-25 EV-EBITDA valuations, due to its dominance...20 Jun, 2023, 02.31 PM IST
- Pharma CMOs may feel heat as USFDA approves fewer new drugs, GlobalData report saysInflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, stated GlobalData in its latest ...06 Apr, 2023, 05.31 PM IST
- JB Pharma Q3 Results: Net profit rises 26% to Rs 106 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 28% YoY to Rs 193 crore. The EBTIDA margin dropped 120 basi...08 Feb, 2023, 08.45 PM IST
- Aurobindo Pharma's arm to invest around Rs 300 crore for biologics manufacturing facilitiesThe board of directors of CuraTeQ Biologics Pvt Ltd, at its meeting held on Thursday, approved the expansion of its operations by establish...01 Sep, 2022, 09.37 PM IST
- JB Pharma net profit down 12% to Rs 105 croreThe company reported net profit of Rs 119 crore during corresponding period of the previous year.The company attributed the drop in net pro...04 Aug, 2022, 10.33 PM IST
- Maharashtra CM, Governor not to accompany PM during his SII visit in PuneAfter Ahmedabad, the PM is scheduled to visit vaccine maker Bharat Biotech's facility in Hyderabad, after which he will proceed to Pune, wh...28 Nov, 2020, 12.57 PM IST
- Buy Jubilant Life, target Rs 867: Anand RathiJLS revenue from operations improved by 5.0% year-on-year to Rs 21,819 million.21 Aug, 2019, 11.58 AM IST
- Sun Pharmaceutical signs agreement with Samsung BioLogics for psoriasis drugThe novel drug known as Tildrakizumab is currently under review by the US FDA and the European Medicines Agency (EMA). The value of the con...05 Jul, 2017, 01.15 AM IST
- Outperform Jubilant Life Sciences Ltd., target Rs 590.0 : Macquarie Capital SecuritiesThe speciality sales (CMO / Radiopharma) are the biggest margin lever for the company. The pharma business provides much-needed stability t...31 Aug, 2016, 02.07 PM IST
- Piramal's pharma solution arm to invest $40 million in new technologyPiramal Enterprises' Pharma Solution division, a global leader in contract development and manufacturing said it plans to invest $40 mn in ...13 Jan, 2015, 05.57 PM IST
- Chhattisgarh sterilisation deaths: Officer says antibiotics had Mumbai pharma stampChhattisgarh health department on Thursday raided two pharma companies, Mahawar Pharma Pvt Ltd at Raipur and Kavita Pharmaceuticals in Bila...14 Nov, 2014, 11.49 AM IST
- Japan's Meiji acquires Bangalore-based Medreich for $290 millionThe acquisition is through the operating subsidiaries, Meiji Seika Pharma Co Ltd, the company said in a filing to the Tokyo Stock Exchange.11 Jun, 2014, 09.09 PM IST
- CRAM sector has been growing at 15-20%: Jubilant OrganosysHari Bhartia, co-chairman & managing director, Jubilant Organosys, in a chat with ET Now talks about the CRAM sector.22 Feb, 2010, 01.15 PM IST
- Macquarie initiates coverage with an ‘Outperform’ on JubilantMacquarie initiates coverage with an ‘Outperform’ rating on Jubilant Organosys and a target price of Rs 450.21 Dec, 2009, 06.27 AM IST
- Religare assigns 'buy' to Jubilant on Draxis buy; target Rs 405The acquisition of Canada-based Draxis Health is expected to enhance Jubilant Organosys’ presence in the regulated markets of North America...07 Apr, 2008, 04.09 PM IST
Load More
